Ignite Creation Date:
2025-12-24 @ 7:01 PM
Ignite Modification Date:
2025-12-29 @ 8:31 PM
Study NCT ID:
NCT04601857
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-03-04
First Post:
2020-10-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Futibatinib and Pembrolizumab Combination in the Treatment of Advanced or Metastatic Urothelial Carcinoma
Sponsor:
Taiho Oncology, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-21
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-08
Completion Date Type:
ESTIMATED
First Submit Date:
2020-10-15
First Submit QC Date:
None
Study First Post Date:
2020-10-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-03-04
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-03-03
Last Update Post Date:
2025-03-04
Last Update Post Date Type:
ACTUAL